Stock ID Number: 515 710
ISIN: DE0005157101
SE Code: HNL
Reuters Code: HNLG.DE
Bloomberg Code: HNL GR
Market Segment: Prime Standard
The Hönle share is listed in the following indices
Index (ISIN)
CDAX (DE0008469602)
Prime All Share (DE0007203325)
Technology All Share (DE0008468943)
Prime Industrial (DE0009660282)
Prime IG Advanced Industrial Equipment (DE0007203895)
Payment Authority
M.M. Warburg & CO Bank, Hamburg, Germany
Number of shares
6,062,930 shares of common stock with a par value of 1 Euro per share in the capital stocktal
Capital stock: € 6.062.930
Registered head office
Dr. Hönle AG
Nicolaus-Otto-Str. 2
82205 Gilching
Date of Update: 01/01/2023
2023
| 12 Dec 23 |
Warburg Research buy, target € 30 Article |
| 11 Dec 23 |
Hauck Aufhäuser buy, target € 29.30 Article |
| 18 Sep 23 |
Warburg Research buy, target € 34 Article |
| 24 Aug 23 |
Hauck Aufhäuser buy, target € 29.30 Article |
| 8 Aug 23 |
Warburg Research buy, target € 34 Article |
| 5 Jun 23 |
Warburg Research buy, target € 34 Article |
| 16 May 23 |
Warburg Research buy, target € 36 Article |
| 22 Feb 23 |
Warburg Research buy, target € 39 Article |
| 22 Feb 23 |
Hauck Aufhäuser buy, target € 37.5 Article |
| 10 Jan 23 |
Hauck Aufhäuser buy, target € 37.50 Article |
2022
| Dec 22 |
Warburg Research buy, target € 39 Article |
| Dec 22 |
Hauck Aufhäuser buy, target € 37.50 Article |
| Dec 22 |
Warburg Research buy, target € 39 Article |
| Dec 22 |
Warburg Research buy, target € 39 Article |
| Dec 22 |
Hauck Aufhäuser buy, target € 37.50 Article |
| Nov 22 |
Warburg Research buy, target € 40 Article |
| Nov 22 |
Hauck Aufhäuser buy, target € 37.50 Article |
| Aug 22 |
Warburg Research buy, target € 43 Article |
| Jul 22 |
Hauck Aufhäuser buy, target € 37,50 Article |
| Jun 22 |
Hauck Aufhäuser buy, target € 50 Article |
| Mai 22 |
Warburg Research buy, target € 52 Article |
| Mar 22 |
Hauck Aufhäuser buy, target € 50 Article |
| Feb 22 |
Warburg Research buy, target € 57 Article |
Disclaimer
The articles and analyses published on our web pages are intended only for informational purposes and do not represent offers for the purchase or selling of securities or other investment instruments. The present data are compiled to the best of our knowledge and in good faith. With regard to future-related statements neither Dr. Hönle AG nor any of the associated companies can assume responsibility for the occurrence of the forecast. Due to changing general economic conditions or other factors beyond the control of Dr. Hönle AG, future results may differ considerably from the forecast. Irrespective of legal obligations for adjusting forecasts, Dr. Hönle AG does not intend to continually update all statements related to the future.